Biogen (BIIB) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free BIIB Stock Alerts $230.57 +0.53 (+0.23%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 5:21 AM | americanbankingnews.comTruist Financial Reiterates "Buy" Rating for Biogen (NASDAQ:BIIB)May 18 at 2:26 AM | americanbankingnews.comBiogen Inc. (NASDAQ:BIIB) Given Average Recommendation of "Moderate Buy" by BrokeragesMay 17 at 6:37 PM | markets.businessinsider.comIonis, Biogen Down on Ending Development of ALS DrugMay 16 at 10:34 PM | markets.businessinsider.comBiogen: A Balanced View Amidst Setbacks and Alzheimer’s Drug PotentialMay 16 at 5:34 PM | msn.comBiogen and Ionis Pharma shares slide as they end development of ALS treatmentMay 16 at 5:34 PM | msn.comTale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For AnotherMay 16 at 3:17 PM | marketbeat.comBiogen (NASDAQ:BIIB) Given "Buy" Rating at Truist FinancialTruist Financial reaffirmed a "buy" rating and set a $340.00 price objective on shares of Biogen in a research report on Thursday.May 16 at 12:33 PM | finanznachrichten.deIonis Pharmaceuticals, Inc.: Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisMay 16 at 12:33 PM | yahoo.comBiogen, Ionis to discontinue development of experimental ALS drugMay 16 at 12:33 PM | marketwatch.comBiogen, Ionis Terminate Development of BIIB105 for Amyotrophic Lateral SclerosisMay 16 at 12:33 PM | finance.yahoo.comREFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drugMay 16 at 11:24 AM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Purchases 7,683 Shares of Biogen Inc. (NASDAQ:BIIB)Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 5.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,428 shares of the biotechnology company's stock afterMay 16 at 7:41 AM | reuters.comBiogen, Ionis to discontinue development of ALS drugMay 16 at 7:30 AM | globenewswire.comBiogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisMay 16 at 7:30 AM | prnewswire.comIonis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisMay 15 at 4:24 PM | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Taysha Gene Therapies (TSHA), Biogen (BIIB)May 15 at 4:24 PM | finance.yahoo.comBiogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's TreatmentMay 15 at 12:49 PM | marketbeat.comQuotient Wealth Partners LLC Purchases New Stake in Biogen Inc. (NASDAQ:BIIB)Quotient Wealth Partners LLC acquired a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 13,313 shares of the biotechnology company's stock, valued atMay 15 at 11:23 AM | msn.comBiogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapyMay 15 at 7:11 AM | marketbeat.comBiogen Q1 Earnings TranscriptMay 15 at 1:20 AM | markets.businessinsider.comEisai Initiates Rolling BLA To FDA For LEQEMBI For Early Alzheimer's Disease TreatmentMay 15 at 1:20 AM | finance.yahoo.comUPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDAMay 14, 2024 | finance.yahoo.comEisai starts rolling submission for injectable version of Alzheimer's drug with US FDAMay 14, 2024 | finance.yahoo.comEisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track StatusMay 14, 2024 | globenewswire.comEisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track StatusMay 13, 2024 | marketbeat.comTeacher Retirement System of Texas Has $8.77 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Teacher Retirement System of Texas cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 11.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,870 shares of the biotechnology company'sMay 12, 2024 | marketbeat.comPartnership Wealth Management LLC Buys New Holdings in Biogen Inc. (NASDAQ:BIIB)Partnership Wealth Management LLC bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 6,479 shares of the biotechnology company's stocMay 11, 2024 | marketbeat.comStoneridge Investment Partners LLC Takes $6.29 Million Position in Biogen Inc. (NASDAQ:BIIB)Stoneridge Investment Partners LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 24,322 shares of the biotechnology company's stoMay 11, 2024 | investorplace.com3 S&P 500 Stocks to Rival Nvidia's 2023 Performance in the Second Half of 2024May 9, 2024 | marketbeat.comNational Pension Service Acquires 6,375 Shares of Biogen Inc. (NASDAQ:BIIB)National Pension Service grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 2.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 302,317 shares of the biotechnology company's stockMay 8, 2024 | morningstar.comBiogen Inc Cedear BIIBMay 8, 2024 | finance.yahoo.comJeff Auxier's Firm Dissolves Textainer Group Position, Trims BiogenMay 8, 2024 | marketbeat.comEmpirical Financial Services LLC d.b.a. Empirical Wealth Management Invests $1.35 Million in Biogen Inc. (NASDAQ:BIIB)Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,234 shares of the bioMay 8, 2024 | bizjournals.comStudy shows potential disparities in early access to Biogen, Eisai's Alzheimer's drugMay 6, 2024 | marketbeat.comNational Bank of Canada FI Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)National Bank of Canada FI raised its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 72.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 201,275 shares of the biotechnology company's stock after buying aMay 5, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Position Increased by Channing Capital Management LLCChanning Capital Management LLC boosted its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 13.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 34,103 shares of the biotechnology company's stock after buying an additional 4,077 shMay 5, 2024 | marketbeat.comKirr Marbach & Co. LLC IN Purchases New Position in Biogen Inc. (NASDAQ:BIIB)Kirr Marbach & Co. LLC IN purchased a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 22,247 shares of the biotechnology company's sMay 3, 2024 | marketbeat.com6,088 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Summit Global InvestmentsSummit Global Investments purchased a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,088 shares of the biotechnology company's stock, valued at approximately $1,5May 2, 2024 | globenewswire.comBiogen Reports Progress on Corporate Responsibility PrioritiesMay 2, 2024 | marketbeat.comTruist Financial Corp Sells 9,681 Shares of Biogen Inc. (NASDAQ:BIIB)Truist Financial Corp reduced its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 18.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 41,915 shares of the biotechnology company's stock after selling 9,681 shares during the period. Truist FinaMay 1, 2024 | marketbeat.comRussell Investments Group Ltd. Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Russell Investments Group Ltd. reduced its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 20.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 123,270 shares of the biotechnology company'April 30, 2024 | marketbeat.comBeck Bode LLC Invests $2.76 Million in Biogen Inc. (NASDAQ:BIIB)Beck Bode LLC purchased a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 10,677 shares of the biotechnology company's stock, valued at approximately $2,763,000. Several other hedge fApril 30, 2024 | seekingalpha.comBiogen: Don't Overthink This OneApril 29, 2024 | marketbeat.comVan ECK Associates Corp Buys 231,650 Shares of Biogen Inc. (NASDAQ:BIIB)Van ECK Associates Corp grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,421,196 shares of the biotechnoloApril 29, 2024 | markets.businessinsider.comThe Analyst Landscape: 27 Takes On BiogenApril 29, 2024 | bizjournals.comAt Biogen, CEO Viehbacher got less total pay than many executives last yearApril 29, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Short Interest UpdateBiogen Inc. (NASDAQ:BIIB - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 3,260,000 shares, a decline of 8.2% from the March 31st total of 3,550,000 shares. Based on an average daily volume of 1,220,000 shares, the short-interest ratio is presently 2.7 days. Approximately 2.3% of the company's stock are sold short.April 29, 2024 | marketbeat.comBiogen (NASDAQ:BIIB) Given Outperform Rating at OppenheimerOppenheimer reiterated an "outperform" rating and set a $270.00 price target on shares of Biogen in a report on Monday.April 29, 2024 | finance.yahoo.com10 Most Promising Stocks to Buy Before They Take OffApril 29, 2024 | investorplace.com7 Retirement Stocks to Buy at a 52-Week Low in April Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here BIIB Media Mentions By Week BIIB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.290.50▲Average Medical News Sentiment BIIB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼2916▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: American Electric Power News Today Neurocrine Biosciences News Today Repligen News Today Pinnacle West Capital News Today CRISPR Therapeutics News Today Portland General Electric News Today Denali Therapeutics News Today Gilead Sciences News Today argenx News Today BioNTech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
